Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
European Radiology
Erschienen in: European Radiology 3/2011

01.03.2011 | Oncology

Diffusion weighted imaging in prostate cancer

verfasst von: Cher Heng Tan, Jihong Wang, Vikas Kundra

Erschienen in: European Radiology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Diffusion-weighted imaging has generated substantial interest in the hope that it can be developed into a robust technique to improve the accuracy of MRI for the evaluation of prostate cancer. This technique has the advantages of short acquisition times, no need for intravenous administration of contrast medium, and the ability to study diffusion of water molecules that indirectly reflects tissue cellularity. In this article, we review the existing literature on the utility of DWI in tumour detection, localisation, treatment response, limitations of the technique, how it compares with other imaging techniques, technical considerations and future directions.
Literatur
1.
Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2009) SEER Cancer Statistics Review, 1975–2006. National Cancer Institute, Bethesda, MD. Available via the SEER web site. http://​seer.​cancer.​gov/​csr/​1975_​2006/​, based on November 2008 SEER data submission. Accessed 5 July 2010
2.
Mullerad M, Hricak H, Kuroiwa K, Pucar D, Chen HN, Kattan MW, Scardino PT (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174:2158–2163CrossRefPubMed
3.
Wang L, Mullerad M, Chen HN, Eberhardt SC, Kattan MW, Scardino PT, Hricak H (2004) Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232:133–139CrossRefPubMed
4.
Taneja SS (2006) Prostate biopsy: targeting cancer for detection and therapy. Rev Urol 8:173–182PubMed
5.
Sella T, Schwartz LH, Swindle PW, Onyebuchi CN, Scardino PT, Scher HI, Hricak H (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385CrossRefPubMed
6.
Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H (2008) MR imaging of the prostate in clinical practice. Magma 21:379–392CrossRefPubMed
7.
Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMed
8.
Sonnad SS, Langlotz CP, Schwartz JS (2001) Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8:149–157CrossRefPubMed
9.
Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMed
10.
Xu J, Humphrey PA, Kibel AS, Snyder AZ, Narra VR, Ackerman JJ, Song SK (2009) Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 61:842–850CrossRefPubMed
11.
Provenzale JM, Engelter ST, Petrella JR, Smith JS, MacFall JR (1999) Use of MR exponential diffusion-weighted images to eradicate T2 “shine-through” effect. AJR Am J Roentgenol 172:537–539PubMed
12.
Morgan VA, Kyriazi S, Ashley SE, DeSouza NM (2007) Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 48:695–703CrossRefPubMed
13.
Kim CK, Park BK (2008) Update of prostate magnetic resonance imaging at 3 T. J Comput Assist Tomogr 32:163–172CrossRefPubMed
14.
Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA (2008) Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging–correlation with pathologic findings. Radiology 246:480–488CrossRefPubMed
15.
Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, Moskowitz CS, Grater JE, Reuter VE, Zakian KL, Touijer KA, Koutcher JA (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449–457CrossRefPubMed
16.
Miao H, Fukatsu H, Ishigaki T (2007) Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 61:297–302CrossRefPubMed
17.
Yoshimitsu K, Kiyoshima K, Irie H, Tajima T, Asayama Y, Hirakawa M, Ishigami K, Naito S, Honda H (2008) Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 27:132–139CrossRefPubMed
18.
Kim CK, Choi D, Park BK, Kwon GY, Lim HK (2008) Diffusion-weighted MR imaging for the evaluation of SVI in prostate cancer: initial results. J Magn Reson Imaging 28:963–969CrossRefPubMed
19.
Kajihara H, Hayashida Y, Murakami R, Katahira K, Nishimura R, Hamada Y, Kitani K, Kitaoka M, Suzuki Y, Kitajima M, Hirai T, Morishita S, Awai K, Yamashita Y (2009) Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys 74:399–403CrossRefPubMed
20.
Park BK, Lee HM, Kim CK, Choi HY, Park JW (2008) Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 43:789–793CrossRefPubMed
21.
Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T, Ito H (2005) Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 29:149–153CrossRefPubMed
22.
Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, Trachtenberg J (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328CrossRefPubMed
23.
Ren J, Huan Y, Wang H, Ge Y, Chang Y, Yin H, Sun L (2009) Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 19:2481–2486CrossRefPubMed
24.
Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection–a multireader study. Radiology 250:145–151CrossRefPubMed
25.
Kim JH, Kim JK, Park BW, Kim N, Cho KS (2008) Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging 28:1173–1179CrossRefPubMed
26.
Ren J, Huan Y, Li F, Wang H, Ge Y, Chang Y, Yin H, Sun L (2009) Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. J Magn Reson Imaging 30:351–356CrossRefPubMed
27.
Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O, Ishigaki T (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21:258–262CrossRefPubMed
28.
Gibbs P, Tozer DJ, Liney GP, Turnbull LW (2001) Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46:1054–1058CrossRefPubMed
29.
Van As N, Charles-Edwards E, Jackson A, Jhavar S, Reinsberg S, Desouza N, Dearnaley D, Bailey M, Thompson A, Christmas T, Fisher C, Corbishley C, Sohaib S (2008) Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol 81:456–462CrossRefPubMed
30.
Ren J, Huan Y, Wang H, Zhao H, Ge Y, Chang Y, Liu Y (2008) Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging 33:724–728CrossRefPubMed
31.
Potter SR, Epstein JI, Partin AW (2000) SVI by prostate cancer: prognostic significance and therapeutic implications. Rev Urol 2:190–195PubMed
32.
Tempany C, Straus S, Hata N, Haker S (2008) MR-guided prostate interventions. J Magn Reson Imaging 27:356–367CrossRefPubMed
33.
Kumar V, Jagannathan NR, Kumar R, Das SC, Jindal L, Thulkar S, Gupta SD, Dwivedi SN, Roell S, Hemal AK, Gupta NP (2006) Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging 24:541–548CrossRefPubMed
34.
DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ, Sklar GN, Alexander RB, Yu C (2002) Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52:429–438CrossRefPubMed
35.
Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, KurhanewiTZ J (2004) Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 59:1196–1207CrossRefPubMed
36.
Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, Imai S, Fukunaga M (2008) Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 248:531–539CrossRefPubMed
37.
Zelhof B, Pickles M, Liney G, Gibbs P, Rodrigues G, Kraus S, Turnbull L (2009) Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103:883–888CrossRefPubMed
38.
Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW (2009) Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 44:572–576CrossRefPubMed
39.
deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C (2008) Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774–782CrossRefPubMed
40.
Rouvière O, Mège-Lechevallier F, Chapelon JY, Gelet A, Bouvier R, Boutitie F, Lyonnet D (2006) Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation. Eur Urol 50:490–497CrossRefPubMed
41.
Chen J, Daniel BL, Diederich CJ, Bouley DM, van den Bosch MA, Kinsey AM, Sommer G, Pauly KB (2008) Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med 59:1365–1372CrossRefPubMed
42.
Kim CK, Park BK, Lee HM, Kim SS, Kim E (2008) MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 190:1180–1186CrossRefPubMed
43.
Kim CK, Park BK, Park W, Kim SS (2010) Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 35:246–252CrossRefPubMed
44.
Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143CrossRefPubMed
45.
Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM (2009) Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed 22:318–325CrossRefPubMed
46.
Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS (2007) Functional MR imaging of prostate cancer. Radiographics 27:63–77CrossRefPubMed
47.
Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152CrossRefPubMed
48.
Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ (2008) Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 49:602–610CrossRefPubMed
49.
Gibbs P, Pickles MD, Turnbull LW (2006) Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 41:185–188CrossRefPubMed
50.
Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM (2007) Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188:91–98CrossRefPubMed
51.
Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229:248–254CrossRefPubMed
52.
Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE (2004) Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging–initial experience. Radiology 233:709–715CrossRefPubMed
53.
White S, Hricak H, Forstner R et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390PubMed
54.
Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K (2010) Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 31:625–631CrossRefPubMed
55.
Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maier SE, Cohen JS, Orenstein A, Mardor Y (2004) High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 232:685–692CrossRefPubMed
56.
Issa B (2002) In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 16:196–200CrossRefPubMed
57.
Qayyum A (2009) Diffusion-weighted Imaging in the Abdomen and Pelvis: Concepts and Applications. Radiographics 1797–1810
58.
Naganawa S, Kawai H, Fukatsu H, Sakurai Y, Aoki I, Miura S, Mimura T, Kanazawa H, Ishigaki T (2005) Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 4:175–186CrossRefPubMed
59.
Kitajima K, Kaji Y, Kuroda K, Sugimura K (2008) High b-value diffusion-weighted imaging in normal and malignant PZ tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 7:93–99CrossRefPubMed
60.
DeLano MC, Cooper TG, Siebert JE, Potchen MJ, Kuppusamy K (2000) High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. AJNR Am J Neuroradiol 21:1830–1836PubMed
61.
Hosseinzadeh K, Schwarz SD (2004) Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20:654–661CrossRefPubMed
62.
Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haidr MA (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327–334CrossRefPubMed
63.
Bilgili Y, Unal B (2004) Effect of region of interest on interobserver variance in apparent diffusion coefficient measures. AJNR Am J Neuroradiol 25:108–111PubMed
64.
Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, Haider MA (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2–sparse versus dense cancers. Radiology 249:900–908CrossRefPubMed
65.
Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, Tempany CM (2006) Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 24:563–568CrossRefPubMed
66.
Shinmoto H, Oshio K, Tanimoto A, Higuchi N, Okuda S, Kuribayashi S, Mulkern RV (2009) Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging 27:355–359CrossRefPubMed
67.
Sinha S, Sinha U (2004) In vivo diffusion tensor imaging of the human prostate. Magn Reson Med 52:530–537CrossRefPubMed
68.
Gürses B, Kabakci N, Kovanlikaya A, Firat Z, Bayram A, Uluğ AM, Kovanlikaya I (2008) Diffusion tensor imaging of the normal prostate at 3 Tesla. Eur Radiol 18:716–721CrossRefPubMed
69.
Chan I, Wells W 3rd, Mulkern RV, Haker S, Zhang J, Zou KH, Maier SE, Tempany CM (2003) Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. Med Phys 30:2390–2398CrossRefPubMed
70.
Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology 255:89–99CrossRefPubMed
71.
Kurhanewicz J, Vigneron D, Carroll P, Coakley F (2008) Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18:71–77CrossRefPubMed
Metadaten
Titel
Diffusion weighted imaging in prostate cancer
verfasst von
Cher Heng Tan
Jihong Wang
Vikas Kundra
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 3/2011
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1960-y

Weitere Artikel der Ausgabe 3/2011

European Radiology 3/2011 Zur Ausgabe

Cardiac

Dose levels at coronary CT angiography—a comparison of Dual Energy-, Dual Source- and 16-slice CT

Ultrasound

Assessment of tissue perfusion by contrast-enhanced ultrasound

Editorial

From multislice CT to whole-body biomarker imaging in lymphoma patients

Editorial

Musculoskeletal imaging: current and future trends

Chest

Chest computed tomography using iterative reconstruction vs filtered back projection (Part 2): image quality of low-dose CT examinations in 80 patients

Editorial

Editorial for anniversary issue of European Radiology

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet

29.03.2024 | Diagnostische Radiologie | Nachrichten

Studie bestätigt Potenzial von KI in der Radiologie

26.03.2024 | Koronare Herzerkrankung | Nachrichten

Quantitative Angiografie könnte IVUS-Alternative darstellen
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen